drug · small molecule
dabrafenib mesylate
Phase 3updated 3mo agoby $NVS NOVARTIS AG🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 2 investigational indications.
targets
Serine/threonine-protein kinase B-raf
all catalysts(0)
nothing on the calendar yet
Trials studying dabrafenib mesylate
News(1)
- Labcorp nabs FDA green light for BRAF melanoma diagnosticThe FDA has signed off on Labcorp’s companion diagnostic for patients with advanced melanoma carrying certain BRAF variants.fiercebiotech · 7d ago
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that